SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Christopher Reeve — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientChristopher Reeve
Date of birth1952-09-25
IdentifiersMRN HR-ML024-SYN-TD; SSN (made up) 000-24-7765
Document date2003-10-26
AuthorTeresa Galloway, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Six-month review: respiratory care, skin, bladder and kidney surveillance, vaccines, and plans for the winter. [S]

History of Present Illness

Mr. Reeve returns six months after his first visit. He uses the pacer for three hours twice a day and the ventilator otherwise, with no respiratory infection since intake. His skin has stayed intact. He has had no symptoms of autonomic dysreflexia. His bladder and bowel programs are working, and he has had no unplanned hospital stay. His stool immunochemical test, HIV and hepatitis C screening from the preventive visit were negative. He feels well and wants to be protected for the winter, when he plans to keep traveling. [S]

ElementDetail
BreathingPacer three hours twice a day; no infections
SkinIntact
Screening resultsStool test, HIV and hepatitis C negative
MoodGood; PHQ-9 2

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever or weight change
RespiratoryNegativeSecretions thin and clear
CardiovascularNegativeNo pounding headaches or flushing; no leg swelling
GenitourinaryNegativeCatheter draining well
IntegumentaryNegativeNo lasting redness
PsychiatricNegativeMood good

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Sennosides 8.6 mg oral tablet, two tablets at bedtimeTwo tablets at bedtimeOral route2003-04-13activeS
Nitroglycerin 2% ointment, one inch to the skin of the chest only if systolic blood pressure stays at 150 mmHg or higher after the first steps of the autonomic dysreflexia plan; wipe off when pressure fallsAs needed for autonomic dysreflexia, under the written planTopical route2003-04-13activeS
Acetaminophen 500 mg oral tablet, two tablets up to three times a day as needed for neck and shoulder achingTwo tablets up to three times a day as neededOral route2003-04-13activeS
Cholecalciferol (vitamin D3) 1977 units (50 mcg) oral capsule, one capsule dailyOne capsule dailyOral route2003-04-27activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2003-10-26Body height193cmS
2003-10-26Body weight83kgS
2003-10-26Body mass index (BMI) [Ratio]22.3kg/m2S
2003-10-26Systolic blood pressure104mm[Hg]S
2003-10-26Diastolic blood pressure64mm[Hg]S
2003-10-26Heart rate60/minS
2003-10-26Respiratory rate12/minS
2003-10-26Body temperature36.3CelS
2003-10-26Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2003-10-26Leukocytes [#/volume] in Blood by Automated count6.810*3/uL4-11 10*3/uLNormalS
2003-10-26Hemoglobin [Mass/volume] in Blood13.4g/dL13.2-16.6 g/dLNormalS
2003-10-26Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2003-10-26Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2003-10-26Creatinine [Mass/volume] in Serum or Plasma0.49mg/dL0.74-1.35 mg/dLLowS
2003-10-26Cystatin C [Mass/volume] in Serum or Plasma0.91mg/L0.53-0.95 mg/LNormalS
2003-10-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Cystatin C-based formula/1.73 sq M92mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2003-10-26Albumin [Mass/volume] in Serum or Plasma4g/dL3.5-5.2 g/dLNormalS
2003-10-26Braden scale total score12{score}S
2003-10-26Pain severity - 0-10 verbal numeric rating [Score] - Reported2{score}S
2003-10-26Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]2{score}S

Physical Exam

Vital signs recorded on 2003-10-26; see the Vital Signs section. [S]

SystemFinding
GeneralWell; weight 83.0 kg by chair scale; blood pressure 104/64, pulse 60
RespiratoryOn the ventilator during the visit; clear; stoma and pacer lead sites clean
SkinIntact at all pressure points; Braden score 12
ExtremitiesNo leg swelling; modified Ashworth 1 in the legs
PsychiatricEngaged and good-humored

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic incomplete C2 tetraplegia (ASIA grade C) from a traumatic spinal cord injury in a riding fall eight years ago, with partial late recovery of sensation and movement; uses a power wheelchair and has 24-hour nursing support; at risk of autonomic dysreflexia; synthetic modern episode linked to his documented injury and his physicians' published reportactiveconfirmed G82.52S — Synthetic modern coding of the documented injury and the published ASIA grade.
Chronic ventilatory failure from the high cervical injury: dependent on a ventilator through a tracheostomy, with a diaphragm pacing system implanted some weeks ago and a conditioning program to lengthen time on the pacer; synthetic modern episode linked to his documented ventilator use and pacingactiveconfirmed Z99.11S — Synthetic modern coding of the documented ventilator dependence.
Neurogenic bladder after spinal cord injury, managed with an indwelling catheteractiveconfirmed N31.9S — Synthetic; expected with this level of injury. No public source describes his bladder care.
Neurogenic bowel after spinal cord injury, managed with a daily morning bowel programactiveconfirmed K59.2S — Synthetic; expected with this level of injury. No public source describes his bowel care.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationAutonomic dysreflexia: episodes, baseline blood pressure, written plan, and nurse trainingEvery visitCompleted todayNo episodes in six months; plan reviewed with two new relief nurses
SurveySkin check and Braden scaleEvery visitCompleted todayIntact; Braden 12
Self-managementSeating, cushion, and pressure mappingAt least yearly and after any change in equipment, weight or skinUp to dateMapped and adjusted two months ago
Self-managementCatheter care and urinary symptomsEvery visitCompleted todayNo symptoms; changes on schedule
LaboratoryKidney function (cystatin C; creatinine unreliable with low muscle mass)At baseline, then every 6 to 12 monthsCompleted todayCystatin C 0.91 mg/L, eGFR 92; sodium 138, potassium 4.1 mmol/L; creatinine 0.49 mg/dL
ImagingKidney and bladder ultrasoundYearlyUp to dateNormal upper tracts six months ago; next in six months
LaboratoryBlood count and albuminEvery 6 to 12 monthsCompleted todayWhite cells 6.8, hemoglobin 13.4 g/dL; albumin 4.0 g/dL
Self-managementBowel programEvery visitCompleted todayEffective
ExaminationPacer conditioning, oxygen saturation, and secretion clearanceEvery visitCompleted todayPacer three hours twice a day; no infections; winter plan written
Self-managementBackup ventilator, suction, cough-assist device, and power planEvery visit, with monthly checks by his nursesCompleted todayChecks up to date; winter power plan confirmed
ImagingBone density (DXA of the hip and knee regions)Baseline, then every 2 yearsUp to dateNext in about eighteen months
LaboratoryLipids, A1c, and blood pressureYearlyDueDue at the one-year review
SurveyDepression screen (PHQ-9)At intake, then every 6 to 12 months and with any changeCompleted todayPHQ-9 2
SurveyPain score and pain planEvery visitCompleted todayPain score 2
ExaminationSpasticity and range of motionEvery visitCompleted todayModified Ashworth 1; daily ranging
ExaminationVenous thromboembolism: leg swellingEvery visit; prophylaxis only during acute illness, surgery or immobilizationCompleted todayNo leg swelling
Self-managementInfluenza, COVID-19 and hepatitis B vaccinesInfluenza and COVID-19 each season; hepatitis B two doses a month apartCompleted todayAll given today; hepatitis B dose 2 in one month
ReferralSpinal cord injury medicine reviewAt least yearlyUp to dateNext review with Dr. Kovac after the winter

Goal progress:

Immunizations given today: Influenza vaccine, inactivated, this season; COVID-19 vaccine, mRNA, this season; Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]

Guideline basis: Evaluation and Management of Autonomic Dysreflexia and Other Autonomic Dysfunctions: Preventing the Highs and Lows (Consortium for Spinal Cord Medicine) (2021); Pressure Ulcer Prevention and Treatment Following Spinal Cord Injury: A Clinical Practice Guideline for Health-Care Providers, Second Edition (Consortium for Spinal Cord Medicine) (2014); Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers (Consortium for Spinal Cord Medicine) (2006); The AUA/SUFU Guideline on Adult Neurogenic Lower Urinary Tract Dysfunction: Treatment and Follow-up (2021); Management of Neurogenic Bowel Dysfunction in Adults after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers (Consortium for Spinal Cord Medicine) (2021); Respiratory management following spinal cord injury: a clinical practice guideline for health-care professionals (Consortium for Spinal Cord Medicine) (2005); Bone Health and Osteoporosis Management in Individuals with Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers (Consortium for Spinal Cord Medicine) (2022); Identification and Management of Cardiometabolic Risk after Spinal Cord Injury: Clinical Practice Guideline for Health Care Providers (Consortium for Spinal Cord Medicine) (2018); Management of Mental Health Disorders, Substance Use Disorders, and Suicide in Adults with Spinal Cord Injury: Clinical Practice Guideline for Healthcare Providers (Consortium for Spinal Cord Medicine) (2021); Prevention of Venous Thromboembolism in Individuals with Spinal Cord Injury: Clinical Practice Guidelines for Health Care Providers, 3rd ed. (Consortium for Spinal Cord Medicine) (2016); Evaluation and Management of Pain After Spinal Cord Injury (Consortium for Spinal Cord Medicine) (2026); CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026); Adult Immunization Schedule by Age (2026)

Follow-up: Hepatitis B dose 2 in one month and the second zoster dose by early in the new year. Review in three months, or the same day for fever, a chest infection, skin redness that does not fade, or autonomic dysreflexia that does not settle with the plan. [S]